EMCDDA Home
  • EN

Table PPP-5. Potency of cannabis products at retail level, 2011

Part (iii) Geographical coverage / sampling frame / type of study

CountryGeographical coverage / Sampling frame / Type of study
BelgiumNational / seizures sent to the laboratories for analysis following prosecutors' decision / analysis developed by 11 laboratories including data from "Project drugs in circulation"
BulgariaLocal: district of Sofia / all seizures / routine analysis of seizures
Czech RepublicNational / all seizures / routine analysis of seizures in some laboratories; not all analysis and all laboratories are included (permanent data collection twice per year).
GermanyNational / all seizures linked to criminal investigation / routine analysis of seizures
EstoniaNational / all seizures / routine analysis of seizures
Ireland:
FranceNational / all seizures / monitoring system
ItalyNational / seizures under a specific threshold (Latium all seizures) / routine analysis of seizures
LuxembourgNational / all seizures random sampling / monitoring system
HungaryNational / all seizures submitted for analysis of herbal cannabis over 8 g / resin seizures of over 25 g / routine analysis of seizures: THC content means only free THC without THC acid.
MaltaNational / random sample of police and customs seizures / monitoring system
NetherlandsNational / user's level: random test purchases in coffee shops / monitoring system
AustriaNational / seizures under a specific threshold / Seizures when suspicion about the substance / test purchases at street level / routine analysis of seizures
PolandNational / not all seizures (includes material from cultivations) / routine analysis of seizures
PortugalNational / random selected sample of seizures of under 1 g / routine analysis of seizures
RomaniaNational / sampling of all cases (retail or large) for which the authorities requested the potency analysis according UNODC best practice manual; High Performance Liquid Chromatography (HPLC) to quantify THC, CBD and CBN / routine analysis of seizures
SloveniaNational / all seizures: random selection / routine analysis of seizures
SlovakiaNational / all seizures / routine analysis of seizures
FinlandNational / THC purity is measured only when herbal cannabis sample amount is >150 g and the purity test is specially requested / monitoring system
SwedenNational / seizures made by the police / Data is collected continuously throughout the year
United KingdomNational (England and Wales) / seizures, from street-level users when issuing a warning, submitted for analysis to their usual forensic provider by 23 Police Forces participated / ad-hoc study
CroatiaNational / all seizures / routine analysis of seizures
TurkeyNational / seizures sent to the laboratories for analysis due judicial or law enforcement needs
NorwayNational / all seizures / routine analysis of seizures
 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013